These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1974439)

  • 1. The pharmacology of fenoldopam.
    Nichols AJ; Ruffolo RR; Brooks DP
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DA1 dopamine receptors in renal cortical collecting duct.
    Ohbu K; Felder RA
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation.
    Pollock DM; Arendshorst WJ
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F627-35. PubMed ID: 1969238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
    Polak MJ; Taylor DA
    Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX; Gellai M; Brooks DP
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-1 and dopamine-2 mechanisms in the control of renal function.
    Carey RM; Siragy HM; Ragsdale NV; Howell NL; Felder RA; Peach MJ; Chevalier RL
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):59S-63S. PubMed ID: 1974444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
    Zhao RR; Wang PH; Zhang WF; Fennell WH
    Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
    Fontana I; Germi MR; Beatini M; Fontana S; Bertocchi M; Porcile E; Saltalamacchia L; Ornis S; Ghinolfi D; Bonifazio L; Valente U
    Transplant Proc; 2005; 37(6):2474-5. PubMed ID: 16182714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human vasodilator responses to a dopamine agonist: possible mechanisms.
    Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
    J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal dopamine receptors and pre- and post-cAMP-mediated Na+ transport defect in spontaneously hypertensive rats.
    Horiuchi A; Albrecht FE; Eisner GM; Jose PA; Felder RA
    Am J Physiol; 1992 Dec; 263(6 Pt 2):F1105-11. PubMed ID: 1362327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS; Ricci A; Amenta F; Lokhandwala MF
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
    Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W
    J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.